Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial

Nature Medicine · Published 2026-07-01 · DOI 10.1038/s41591-026-04475-7

Free full text

Authors (29)

Michael Lim, Xiaobu Ye, Anna F. Piotrowski, Arati Desai, Manmeet S Ahluwalia, Tobias Walbert, Glenn Lesser, Benjamin M. Ellingson, David M. Peereboom, Joy D. Fisher, Serena Desideri, Christina Jackson, Ayush Pant, Aanchal Jain, Rohit Verma, Benjamin Oberlton, Hadeesha Piyadasa, Chetan Bettegowda, Logan Engle, Janis Taube, Sean C. Bendall, John Choi, Jan Drappatz, Frank S. Lieberman, Lawrence R. Kleinberg, Drew M. Pardoll, Louis B. Nabors, Patrick Y. Wen, Stuart A. Grossman

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Lim, M., Ye, X., Piotrowski, A., et al. (2026). Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04475-7

Related articles